» Articles » PMID: 30184476

Recapitulating Kidney Development: Progress and Challenges

Overview
Date 2018 Sep 6
PMID 30184476
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Decades of research into the molecular and cellular regulation of kidney morphogenesis in rodent models, particularly the mouse, has provided both an atlas of the mammalian kidney and a roadmap for recreating kidney cell types with potential applications for the treatment of kidney disease. With advances in both our capacity to maintain nephron progenitors in culture, reprogram to kidney cell types and direct the differentiation of human pluripotent stem cells to kidney endpoints, renal regeneration via cellular therapy or tissue engineering may be possible. Human kidney models also have potential for disease modelling and drug screening. Such applications will rely upon the accuracy of the model at the cellular level and the capacity for stem-cell derived kidney tissue to recapitulate both normal and diseased kidney tissue. In this review, we will discuss the available cell sources, how well they model the human kidney and how far we are from application either as models or for tissue engineering.

Citing Articles

Autologous adipose-derived mesenchymal stem cell therapy reverses detrusor underactivity: open clinical trial.

Coelho H, Neves S, da Silva Menezes J, Antoniolli-Silva A, Oliveira R Stem Cell Res Ther. 2023; 14(1):64.

PMID: 37016455 PMC: 10074857. DOI: 10.1186/s13287-023-03294-8.


The "3Ds" of Growing Kidney Organoids: Advances in Nephron Development, Disease Modeling, and Drug Screening.

Chambers B, Weaver N, Wingert R Cells. 2023; 12(4).

PMID: 36831216 PMC: 9954122. DOI: 10.3390/cells12040549.


Tubuloid culture enables long-term expansion of functional human kidney tubule epithelium from iPSC-derived organoids.

Yengej F, Jansen J, Ammerlaan C, Dilmen E, Pou Casellas C, Masereeuw R Proc Natl Acad Sci U S A. 2023; 120(6):e2216836120.

PMID: 36724260 PMC: 9963523. DOI: 10.1073/pnas.2216836120.


A Concise Review on Electrospun Scaffolds for Kidney Tissue Engineering.

Miranda C, Gomes M, Moco M, Cabral J, Ferreira F, Sanjuan-Alberte P Bioengineering (Basel). 2022; 9(10).

PMID: 36290522 PMC: 9598616. DOI: 10.3390/bioengineering9100554.


Organs-on-chip technology: a tool to tackle genetic kidney diseases.

Valverde M, Faria J, Sendino Garvi E, Janssen M, Masereeuw R, Mihaila S Pediatr Nephrol. 2022; 37(12):2985-2996.

PMID: 35286457 PMC: 9587109. DOI: 10.1007/s00467-022-05508-2.


References
1.
Freedman B, Brooks C, Lam A, Fu H, Morizane R, Agrawal V . Modelling kidney disease with CRISPR-mutant kidney organoids derived from human pluripotent epiblast spheroids. Nat Commun. 2015; 6:8715. PMC: 4620584. DOI: 10.1038/ncomms9715. View

2.
Figliuzzi M, Bonandrini B, Remuzzi A . Decellularized kidney matrix as functional material for whole organ tissue engineering. J Appl Biomater Funct Mater. 2017; 15(4):e326-e333. DOI: 10.5301/jabfm.5000393. View

3.
Bertram J, Douglas-Denton R, Diouf B, Hughson M, Hoy W . Human nephron number: implications for health and disease. Pediatr Nephrol. 2011; 26(9):1529-33. DOI: 10.1007/s00467-011-1843-8. View

4.
Altman G, Diaz F, Jakuba C, Calabro T, Horan R, Chen J . Silk-based biomaterials. Biomaterials. 2002; 24(3):401-16. DOI: 10.1016/s0142-9612(02)00353-8. View

5.
Kim J, Efe J, Zhu S, Talantova M, Yuan X, Wang S . Direct reprogramming of mouse fibroblasts to neural progenitors. Proc Natl Acad Sci U S A. 2011; 108(19):7838-43. PMC: 3093517. DOI: 10.1073/pnas.1103113108. View